Welcome to MS Views and News blog


MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

February 28, 2023

Lower-dose gadolinium now being used for MRIs with contrast

  • Marketing
    /
 by Ed Tobias | February 24, 2023 If you have multiple sclerosis (MS), I’m sure you’ve had several MRIs by now. You’ve probably also…
Marketing

February 28, 2023

Favorable Safety Outcomes Observed in Ozanimod (#Zeposia) Over Diroximel Fumarate (Vumerity)

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
 Feb 26, 2023 – Marco Meglio        – #ACTRIMS Conferences: Americas Committee for Treatment and Research in Multiple Sclerosis…
MS Drug Therapies

February 27, 2023

Patients With NMOSD ( neuromyelitis optica spectrum disorder ) Relapse Events Experience High Economic Burden

  • NMO (NMOSD/Devics)
    /
 #ACTRIMS                #NMOSD Feb 27, 2023          Isabella Ciccone, MPH A…
NMO (NMOSD/Devics)

February 27, 2023

Metabolic Changes, Cognitive Improvements in Multiple Sclerosis Observed Through Intermittent Calorie Restriction

  • MS Research Study and Reports
    /
 Feb 27, 2023 –   Marco Meglio Compared with those on an unrestricted diet, patients with MS on intermittent calorie restriction…
MS Research Study and Reports

February 27, 2023

Gauging MS Disease Activity Through Octave’s MSDA Test

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
 Feb 24, 2023    Taylor Gonyou, DO The multiple sclerosis fellow at Michigan Institute for Neurologic Disorders provided perspective on…
MS Research Study and Reports

February 27, 2023

BTK Inhibitor Evobrutinib Displays Superior Efficacy Compared With Anti-CD20 Treatment for MS

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
 Feb 25, 2023 – Isabella Ciccone, MPH A preclinical assessment of evobrutinib showed it demonstrated superior efficacy in targeting compartmentalized…
MS Drug Therapies

February 27, 2023

Ocrelizumab and Rituximab Demonstrate Similar Safety, Efficacy in Treatment of Multiple Sclerosis

  • MS Research Study and Reports
    /
  • Ocrevus
    /
 Treatment with either rituximab and ocrelizumab, 2 FDA-approved therapies that target CD20, resulted in similar odds of experiencing a clinical…
MS Research Study and Reports

February 20, 2023

Omega-3 fatty acid reduced disease severity in MS mouse model

  • MS Research Study and Reports
    /
  • Vitamins and Supplements
    /
Study findings could lead to new solutions in managing MS symptoms by Marisa Wexler, MS | February 16, 2023 Treatment…
MS Research Study and Reports

February 16, 2023

Vitamin D Deficiency: Causes, Symptoms & Treatment

  • Vitamins and Supplements
    /
 Vitamin D deficiency is a common vitamin deficiency that causes issues with your bones and muscles. It most commonly affects…
Vitamins and Supplements

February 16, 2023

15 Symptoms of Vitamin B12 Deficiency

  • Vitamins and Supplements
    /
  As we age, vitamin B12 becomes even more important — our mood, memory, nerve cells, and blood cells depend…
Vitamins and Supplements

Categories

Latest Blog Posts